{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:45:32Z","timestamp":1787510732501,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parkinson\u2019s disease (PD) shows substantial variability in presentation and progression. Frailty, a multidimensional construct reflecting biological aging, is a determinant of clinical outcomes in several neurodegenerative disorders. While cross-sectional studies suggest that frailty modulates the clinical phenotype of PD, affecting motor and non-motor symptoms, its longitudinal prognostic relevance remains unclear. In this 3-year, single-center cohort study, we investigated whether frailty, measured using a validated 50-item frailty index (FI), predicts clinical progression, motor complications, and mortality in a cohort of 109 PD patients. Clinical assessment included MDS-UPDRS parts III and IV, Non-Motor Symptoms Scale, Hoehn &amp; Yahr stage, Montreal Cognitive Assessment, and levodopa equivalent daily dose (LEDD). Associations between baseline FI and follow-up outcomes were examined using simple and multiple linear regression models. Patients were stratified into three frailty groups at baseline to examine group-level differences in clinical progression and mortality, which were assessed using mixed-effects models and contingency analyses. Higher baseline FI independently predicted greater severity of treatment-related motor complications at follow-up (\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2009=\u20098.3;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.04) and greater worsening of these complications over time (\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2009=\u200911.4;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.017) and showed trends toward greater non-motor symptom burden and cognitive decline. No significant association was observed between baseline FI and motor progression. Patients classified as frail at baseline displayed greater clinical deterioration across multiple domains, higher LEDD requirements, and had increased mortality (\u03c7\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u200916.5,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) compared to less frail counterparts. In conclusion, frailty predicts worse clinical trajectories and increased mortality in PD, supporting its utility as a prognostic biomarker. Incorporating frailty assessment into routine care may improve risk stratification and guide personalized therapeutic approaches in PD patients.\n                  <\/jats:p>","DOI":"10.1007\/s11357-026-02148-4","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:22:56Z","timestamp":1771888976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Relationship between frailty and disease progression in Parkinson\u2019s disease: a 3-year longitudinal study"],"prefix":"10.1007","author":[{"given":"Matteo","family":"Costanzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Canevelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ilenia","family":"De Bartolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Valletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Toccaceli","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Leodori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Fabbrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8681-3050","authenticated-orcid":false,"given":"Daniele","family":"Belvisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"2148_CR1","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3233\/JPD-223363","volume":"12","author":"C Coleman","year":"2022","unstructured":"Coleman C, Martin I. Unraveling Parkinson\u2019s disease neurodegeneration: does aging hold the clues? J Parkinsons Dis. 2022;12:2321\u201338. https:\/\/doi.org\/10.3233\/JPD-223363.","journal-title":"J Parkinsons Dis"},{"key":"2148_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13.","journal-title":"Nat Rev Dis Primers"},{"key":"2148_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04356-8","volume":"12","author":"LL Raket","year":"2022","unstructured":"Raket LL, Oudin \u00c5str\u00f6m D, Norlin JM, Kellerborg K, Martinez-Martin P, Odin P. Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson\u2019s disease. Sci Rep. 2022;12:526. https:\/\/doi.org\/10.1038\/s41598-021-04356-8.","journal-title":"Sci Rep"},{"key":"2148_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.909273","volume":"14","author":"IH Kl\u00e6strup","year":"2022","unstructured":"Kl\u00e6strup IH, Just MK, Holm KL, Alstrup AKO, Romero-Ramos M, Borghammer P, et al. Impact of aging on animal models of Parkinson\u2019s disease. Front Aging Neurosci. 2022;14:909273. https:\/\/doi.org\/10.3389\/fnagi.2022.909273.","journal-title":"Front Aging Neurosci"},{"key":"2148_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41380-018-0098-1","volume":"24","author":"JH Cole","year":"2019","unstructured":"Cole JH, Marioni RE, Harris SE, Deary IJ. Brain age and other bodily \u2018ages\u2019: implications for neuropsychiatry. Mol Psychiatry. 2019;24:266\u201381. https:\/\/doi.org\/10.1038\/s41380-018-0098-1.","journal-title":"Mol Psychiatry"},{"key":"2148_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s43587-021-00099-3","volume":"1","author":"SE Howlett","year":"2021","unstructured":"Howlett SE, Rutenberg AD, Rockwood K. The degree of frailty as a translational measure of health in aging. Nat Aging. 2021;1:651\u201365. https:\/\/doi.org\/10.1038\/s43587-021-00099-3.","journal-title":"Nat Aging"},{"key":"2148_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/gerona\/glt162","volume":"69","author":"DJ Lowsky","year":"2014","unstructured":"Lowsky DJ, Olshansky SJ, Bhattacharya J, Goldman DP. Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci. 2014;69:640\u20139. https:\/\/doi.org\/10.1093\/gerona\/glt162.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"2148_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1223-3","volume":"16","author":"K Rockwood","year":"2018","unstructured":"Rockwood K, Howlett SE. Fifteen years of progress in understanding frailty and health in aging. BMC Med. 2018;16(1):220. https:\/\/doi.org\/10.1186\/s12916-018-1223-3.","journal-title":"BMC Med"},{"key":"2148_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/gerona\/62.7.722","volume":"62","author":"K Rockwood","year":"2007","unstructured":"Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62:722\u20137. https:\/\/doi.org\/10.1093\/gerona\/62.7.722.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2148_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-8-24","volume":"8","author":"SD Searle","year":"2008","unstructured":"Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24. https:\/\/doi.org\/10.1186\/1471-2318-8-24.","journal-title":"BMC Geriatr"},{"key":"2148_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.parkreldis.2007.10.004","volume":"14","author":"NN Ahmed","year":"2008","unstructured":"Ahmed NN, Sherman SJ, VanWyck D. <article-title update=\"added\">Frailty in Parkinson\u2019s disease and its clinical implications. Parkinsonism Relat Disord. 2008;14:334\u20137. https:\/\/doi.org\/10.1016\/j.parkreldis.2007.10.004.","journal-title":"Parkinsonism Relat Disord"},{"key":"2148_CR12","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1007\/s00415-021-10873-3","volume":"269","author":"D Belvisi","year":"2022","unstructured":"Belvisi D, Canevelli M, Costanzo M, Giangrosso M, Fabbrini A, Borraccino A, et al. The role of frailty in Parkinson\u2019s disease: a cross-sectional study. J Neurol. 2022;269:3006\u201314. https:\/\/doi.org\/10.1007\/s00415-021-10873-3.","journal-title":"J Neurol"},{"issue":"4","key":"2148_CR13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/gerona\/glaa191","volume":"76","author":"E Ntanasi","year":"2021","unstructured":"Ntanasi E, Maraki M, Yannakoulia M, Stamelou M, Xiromerisiou G, Kosmidis MH, et al. Frailty and prodromal Parkinson\u2019s disease: results from the HELIAD study. J Gerontol A Biol Sci Med Sci. 2021;76(4):622\u20139. https:\/\/doi.org\/10.1093\/gerona\/glaa191.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2148_CR14","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/mds.28561","volume":"36","author":"DS Abraham","year":"2021","unstructured":"Abraham DS, Pham Nguyen TP, Willis AW. <article-title update=\"added\">Claims\u2010based frailty and outcomes: applying an aging measure to older adults with Parkinson\u2019s disease. Mov Disord. 2021;36:1871\u20138. https:\/\/doi.org\/10.1002\/mds.28561.","journal-title":"Mov Disord"},{"key":"2148_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.parkreldis.2022.05.004","volume":"99","author":"MG Borda","year":"2022","unstructured":"Borda MG, P\u00e9rez\u2010Zepeda MU, Jaramillo-Jimenez A, Chaudhuri KR, Tovar-Rios DA, Wallace L, et al. <article-title update=\"added\">Frailty in Parkinson\u2019s disease and its association with early dementia: a longitudinal study. Parkinsonism Relat Disord. 2022;99:51\u20137. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.05.004.","journal-title":"Parkinsonism Relat Disord"},{"key":"2148_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jamaneurol.2023.0183","volume":"80","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Lv Y, Rong S, Sun T, Chen L. Physical frailty, genetic predisposition, and incident Parkinson disease. JAMA Neurol. 2023;80:455. https:\/\/doi.org\/10.1001\/jamaneurol.2023.0183.","journal-title":"JAMA Neurol"},{"key":"2148_CR17","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. <article-title update=\"added\">MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30:1591\u2013601. https:\/\/doi.org\/10.1002\/mds.26424.","journal-title":"Mov Disord"},{"key":"2148_CR18","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mds.29410","volume":"38","author":"ST Jost","year":"2023","unstructured":"Jost ST, Kaldenbach M, Antonini A, Martinez-Martin P, Timmermann L, Odin P, et al. Levodopa dose equivalency in Parkinson\u2019s disease: updated systematic review and proposals. Mov Disord. 2023;38:1236\u201352. https:\/\/doi.org\/10.1002\/mds.29410.","journal-title":"Mov Disord"},{"key":"2148_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/wnl.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427\u201342. https:\/\/doi.org\/10.1212\/wnl.17.5.427.","journal-title":"Neurology"},{"key":"2148_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10072-012-1112-z","volume":"34","author":"A Antonini","year":"2013","unstructured":"Antonini A, Abbruzzese G, Ferini-Strambi L, Tilley B, Huang J, Stebbins GT, et al. Validation of the Italian version of the movement disorder society-unified Parkinson\u2019s Disease rating scale. Neurol Sci. 2013;34:683\u20137. https:\/\/doi.org\/10.1007\/s10072-012-1112-z.","journal-title":"Neurol Sci"},{"key":"2148_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.parkreldis.2016.10.020","volume":"34","author":"I Cova","year":"2017","unstructured":"Cova I, Di Battista ME, Vanacore N, Papi CP, Alampi G, Rubino A, et al. Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson\u2019s disease. Parkinsonism Relat Disord. 2017;34:38\u201342. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.10.020.","journal-title":"Parkinsonism Relat Disord"},{"key":"2148_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x.","journal-title":"J Am Geriatr Soc"},{"key":"2148_CR23","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1177\/1352458520987541","volume":"27","author":"D Belvisi","year":"2021","unstructured":"Belvisi D, Canevelli M, Baione V, Buscarinu MC, Pellicciari G, Fantozzi R, et al. Operationalization of a frailty index in patients with multiple sclerosis: a cross-sectional investigation. Mult Scler. 2021;27:1939\u201347. https:\/\/doi.org\/10.1177\/1352458520987541.","journal-title":"Mult Scler"},{"key":"2148_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3899\/jrheum.181338","volume":"47","author":"A Legge","year":"2020","unstructured":"Legge A, Kirkland S, Rockwood K, Andreou P, Bae S-C, Gordon C, et al. Construction of a frailty index as a novel health measure in systemic lupus erythematosus. J Rheumatol. 2020;47:72\u201381. https:\/\/doi.org\/10.3899\/jrheum.181338.","journal-title":"J Rheumatol"},{"key":"2148_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K. A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J. 2005;173:489\u201395. https:\/\/doi.org\/10.1503\/cmaj.050051.","journal-title":"Can Med Assoc J"},{"key":"2148_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/gps.5270","volume":"35","author":"RA Lawson","year":"2020","unstructured":"Lawson RA, Richardson SJ, Yarnall AJ, Burn DJ, Allan LM. Identifying delirium in Parkinson disease: a pilot study. Int J Geriatr Psychiatry. 2020;35:547\u201352. https:\/\/doi.org\/10.1002\/gps.5270.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2148_CR27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000492572","volume":"65","author":"M Peball","year":"2019","unstructured":"Peball M, Mahlknecht P, Werkmann M, Marini K, Murr F, Herzmann H, et al. Prevalence and associated factors of sarcopenia and frailty in Parkinson\u2019s disease: a cross-sectional study. Gerontology. 2019;65:216\u201328. https:\/\/doi.org\/10.1159\/000492572.","journal-title":"Gerontology"},{"key":"2148_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4997\/jrcpe.2018.201","volume":"48","author":"K Torsney","year":"2018","unstructured":"Torsney K, Romero-Ortuno R. The clinical frailty scale predicts inpatient mortality in older hospitalised patients with idiopathic Parkinson\u2019s disease. J R Coll Physicians Edinb. 2018;48:103\u20137. https:\/\/doi.org\/10.4997\/jrcpe.2018.201.","journal-title":"J R Coll Physicians Edinb"},{"key":"2148_CR29","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010944","author":"LMK Wallace","year":"2020","unstructured":"Wallace LMK, Theou O, Darvesh S, Bennett DA, Buchman AS, Andrew MK, et al. Neuropathologic burden and the degree of frailty in relation to global cognition and dementia. Neurology. 2020. https:\/\/doi.org\/10.1212\/WNL.0000000000010944.","journal-title":"Neurology"},{"key":"2148_CR30","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/mdc3.14044","volume":"11","author":"SE Gandhi","year":"2024","unstructured":"Gandhi SE, Zerenner T, Nodehi A, Lawton MA, Marshall V, Al\u2010Hajraf F, et al. <article-title update=\"added\">Motor complications in Parkinson\u2019s disease: results from 3343 patients followed for up to 12\u2009years. Mov Disord Clin Pract. 2024;11:686\u201397. https:\/\/doi.org\/10.1002\/mdc3.14044.","journal-title":"Mov Disord Clin Pract"},{"key":"2148_CR31","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/mds.27783","volume":"34","author":"MJ Kelly","year":"2019","unstructured":"Kelly MJ, Lawton MA, Baig F, Ruffmann C, Barber TR, Lo C, et al. Predictors of motor complications in early Parkinson\u2019s disease: a prospective cohort study. Mov Disord. 2019;34:1174\u201383. https:\/\/doi.org\/10.1002\/mds.27783.","journal-title":"Mov Disord"},{"key":"2148_CR32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/mds.23068","volume":"25","author":"S Ku","year":"2010","unstructured":"Ku S, Glass GA. Age of Parkinson\u2019s disease onset as a predictor for the development of dyskinesia. Mov Disord. 2010;25:1177\u201382. https:\/\/doi.org\/10.1002\/mds.23068.","journal-title":"Mov Disord"},{"key":"2148_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49617-w","volume":"13","author":"DAB Leal","year":"2023","unstructured":"Leal DAB, Dias CMV, Ramos RP, Brys I. Prediction of dyskinesia in Parkinson\u2019s disease patients using machine learning algorithms. Sci Rep. 2023;13:22426. https:\/\/doi.org\/10.1038\/s41598-023-49617-w.","journal-title":"Sci Rep"},{"key":"2148_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/geriatrics2010006","volume":"2","author":"S Allen","year":"2017","unstructured":"Allen S. Systemic inflammation in the genesis of frailty and sarcopenia: an overview of the preventative and therapeutic role of exercise and the potential for drug treatments. Geriatrics. 2017;2:6. https:\/\/doi.org\/10.3390\/geriatrics2010006.","journal-title":"Geriatrics"},{"key":"2148_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cells12172142","volume":"12","author":"R Inoue","year":"2023","unstructured":"Inoue R, Nishimune H. Neuronal plasticity and age-related functional decline in the motor cortex. Cells. 2023;12:2142. https:\/\/doi.org\/10.3390\/cells12172142.","journal-title":"Cells"},{"key":"2148_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s40520-021-02022-7","volume":"34","author":"Y Xu","year":"2022","unstructured":"Xu Y, Wang M, Chen D, Jiang X, Xiong Z. Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies. Aging Clin Exp Res. 2022;34:971\u201387. https:\/\/doi.org\/10.1007\/s40520-021-02022-7.","journal-title":"Aging Clin Exp Res"},{"key":"2148_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2023.112253","volume":"179","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zeng X, He F, Huang X. Inflammatory biomarkers of frailty: a review. Exp Gerontol. 2023;179:112253. https:\/\/doi.org\/10.1016\/j.exger.2023.112253.","journal-title":"Exp Gerontol"},{"key":"2148_CR38","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1093\/brain\/awab242","volume":"144","author":"A Tozzi","year":"2021","unstructured":"Tozzi A, Sciaccaluga M, Loffredo V, Megaro A, Ledonne A, Cardinale A, et al. Dopamine-dependent early synaptic and motor dysfunctions induced by \u03b1-synuclein in the nigrostriatal circuit. Brain. 2021;144:3477\u201391. https:\/\/doi.org\/10.1093\/brain\/awab242.","journal-title":"Brain"},{"key":"2148_CR39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1468-1331.2009.02900.x","volume":"17","author":"P Barone","year":"2010","unstructured":"Barone P. Neurotransmission in Parkinson\u2019s disease: beyond dopamine. Eur J Neurol. 2010;17:364\u201376. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02900.x.","journal-title":"Eur J Neurol"},{"key":"2148_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol. 2006;5:235\u201345. https:\/\/doi.org\/10.1016\/S1474-4422(06)70373-8.","journal-title":"Lancet Neurol"},{"key":"2148_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18:435\u201350. https:\/\/doi.org\/10.1038\/nrn.2017.62.","journal-title":"Nat Rev Neurosci"},{"key":"2148_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293382","volume":"19","author":"A Khan","year":"2024","unstructured":"Khan A, Ezeugwa J, Ezeugwu VE, Salvatore MF. A systematic review of the associations between sedentary behavior, physical inactivity, and non-motor symptoms of Parkinson\u2019s disease. PLoS One. 2024;19:e0293382. https:\/\/doi.org\/10.1371\/journal.pone.0293382.","journal-title":"PLoS One"},{"key":"2148_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2021.100095","volume":"4","author":"JM McMillan","year":"2021","unstructured":"McMillan JM, Michalchuk Q, Goodarzi Z. Frailty in Parkinson\u2019s disease: a systematic review and meta-analysis. Clin Park Relat Disord. 2021;4:100095. https:\/\/doi.org\/10.1016\/j.prdoa.2021.100095.","journal-title":"Clin Park Relat Disord"},{"key":"2148_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-024-02922-4","volume":"37","author":"MC Sousa-Fraguas","year":"2025","unstructured":"Sousa-Fraguas MC, Rodr\u00edguez-Fuentes G, Lastra-Barreira D, Conejo NM. Associations between frailty and cognitive impairment in Parkinson\u00b4s disease: a cross-sectional study. Aging Clin Exp Res. 2025;37:19. https:\/\/doi.org\/10.1007\/s40520-024-02922-4.","journal-title":"Aging Clin Exp Res"},{"key":"2148_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15010063","volume":"15","author":"D Hern\u00e1ndez-Triana","year":"2025","unstructured":"Hern\u00e1ndez-Triana D, P\u00e1ez-Garc\u00eda S, Mena A, Gimeno M, Soto-Leal A, Rodriguez-Oroz MC, et al. Parkinson\u2019s disease and frailty: a two-way link across aging. J Clin Med. 2025;15:63. https:\/\/doi.org\/10.3390\/jcm15010063.","journal-title":"J Clin Med"},{"key":"2148_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00581-2","volume":"9","author":"C Sotirakis","year":"2023","unstructured":"Sotirakis C, Su Z, Brzezicki MA, Conway N, Tarassenko L, FitzGerald JJ, et al. Identification of motor progression in Parkinson\u2019s disease using wearable sensors and machine learning. NPJ Parkinsons Dis. 2023;9:142. https:\/\/doi.org\/10.1038\/s41531-023-00581-2.","journal-title":"NPJ Parkinsons Dis"},{"key":"2148_CR47","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S1474-4422(24)00291-6","volume":"23","author":"M Canevelli","year":"2024","unstructured":"Canevelli M, Jackson-Tarlton C, Rockwood K. Frailty for neurologists: perspectives on how frailty influences care planning. Lancet Neurol. 2024;23:1147\u201357. https:\/\/doi.org\/10.1016\/S1474-4422(24)00291-6.","journal-title":"Lancet Neurol"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02148-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02148-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02148-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:22:58Z","timestamp":1771888978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02148-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":47,"alternative-id":["2148"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02148-4","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the local ethics committee (n.4734) and conducted according to the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}